Semble has secured £11.6 million in Series B funding, spearheaded by Mercia Ventures.
- The investment aims to support Semble’s expansion into international markets.
- Semble is replacing outdated healthcare IT systems with advanced, integrated solutions.
- Inefficiencies in current systems result in the loss of millions of NHS working hours.
- Founders Christoph Lippuner and Mikael Landau bring expertise from their previous ventures.
London-based Semble has successfully concluded a £11.6 million Series B funding round, led by Mercia Ventures. Founded by Christoph Lippuner and Mikael Landau, Semble aims to expand its operations overseas, enhancing its capabilities in revolutionising healthcare IT systems.
Semble’s mission is to address the inefficiencies caused by outdated technology in the healthcare sector. The British Medical Association estimates that English doctors lose over 13 million working hours annually due to these inefficiencies. Semble offers a robust IT platform designed to automate workflows, facilitate secure data exchanges, and integrate smoothly with third-party systems, aiming to alleviate these challenges.
CEO Christoph Lippuner stated, ‘Amplifying the impact of healthcare professionals is central to our mission. For too long, they have worked with outdated systems that take them away from what matters most – the patient.’ Lippuner and his co-founder, Mikael Landau, previously sold their startup, Orogo, to Just Eat, bringing valuable experience to their current venture.
The latest investment round was supported by Octopus Ventures, Smedvig Ventures, and Triple Point, in addition to the lead by Mercia Ventures. Alex Gwyther from Mercia Ventures commented on the healthcare market’s growth and the persistent reliance on legacy systems, stressing the potential threat they pose to the industry’s future. Gwyther expressed confidence in Semble’s ability to seize the vast market opportunities presented by these challenges.
Previously known as Heydoc, Semble initially gathered $8.3 million during its Series A funding round in September 2021. With the latest funding secured, Semble’s total financial backing has reached $27 million.
The recent funding round positions Semble to advance its mission of modernising healthcare technology on a global scale.
